044 - 35067064
CUSTOMER CARE
044 - 35067064 044 - 35067064
CUSTOMER CARE CUSTOMER CARE
NIRAMAI-Thermalytix breast screening
Parameters : 1
Also known as : NIRAMAI-Thermalytix breast screening
You save   1000
56% OFF
EXCLUSIVE OFFER
1800   800
Report Delivery
2 Days
Free Sample Collection
Bookings above 500
Pre - Instruction
No Preparation Required.
Covid Safety
Assured
Test Details
Test Code BOBT00548
Test Category Individual Test
Sample Type
Details of NIRAMAI-Thermalytix breast screening
What is NIRAMAI-Thermalytix breast screening?
Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates.

We, at NIRAMAI, have developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

The core of NIRAMAI solution is Thermalytix, a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal images. Our SaaS solution has been developed using big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening.

The innovative methods used in our solution have led to 10 Granted US patents.
  1. Privacy booth for breast cancer screening (Granted by USPTO recently)
  2. Classifying hormonal receptor status of malignant tumorous tissue from breast thermographic images, US 10,368,846
  3. Thermography based breast cancer screening using a measure of symmetry, US 10,307,141
  4. Blood vessel extraction in two-dimensional thermography, US 10,198,670
  5. Automatic segmentation of breast tissue in a thermographic image, US 10,068,330
  6. Software tool for breast cancer screening, US 9,898,817
  7. Contour-based determination of malignant tissue in a thermal image, US 9,865,052
  8. Software interface tool for breast cancer screening, US 10,055,542
  9. System and method for detecting cancerous tissue from a thermal image, US 9,622,698
  10. Detecting tumorous breast tissue in a thermal image, US 9,486,146
Routine Tests
NIRAMAI-Thermalytix breast screening
Parameters : 1
Also known as : NIRAMAI-Thermalytix breast screening
You save   1000
56% OFF
EXCLUSIVE OFFER
1800   800
Report Delivery
2 Days
Free Sample Collection
Bookings above 500
Pre - Instruction
No Preparation Required.
Covid Safety
Assured
Test Details
Test Code BOBT00548
Test Category Individual Test
Sample Type
Details of NIRAMAI-Thermalytix breast screening
What is NIRAMAI-Thermalytix breast screening?
Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates.

We, at NIRAMAI, have developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

The core of NIRAMAI solution is Thermalytix, a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal images. Our SaaS solution has been developed using big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening.

The innovative methods used in our solution have led to 10 Granted US patents.
  1. Privacy booth for breast cancer screening (Granted by USPTO recently)
  2. Classifying hormonal receptor status of malignant tumorous tissue from breast thermographic images, US 10,368,846
  3. Thermography based breast cancer screening using a measure of symmetry, US 10,307,141
  4. Blood vessel extraction in two-dimensional thermography, US 10,198,670
  5. Automatic segmentation of breast tissue in a thermographic image, US 10,068,330
  6. Software tool for breast cancer screening, US 9,898,817
  7. Contour-based determination of malignant tissue in a thermal image, US 9,865,052
  8. Software interface tool for breast cancer screening, US 10,055,542
  9. System and method for detecting cancerous tissue from a thermal image, US 9,622,698
  10. Detecting tumorous breast tissue in a thermal image, US 9,486,146
© Copyright 2019 All Rights Reserved Bloodoxy Scans And Labs